Google Alert - pharmaceutical news

News 10 new results for pharmaceutical news

Pfizer job cuts highlight Irish exposure to patent expiries Reuters India DUBLIN (Reuters) - Pfizer Inc will cut 177 jobs in Ireland following the expiration of patents on blockbuster cholesterol drug Lipitor, highlighting the exposure of Ireland's export-driven economy to the patent cliff facing many in the pharmaceutical ... See all stories on this topic »

Ohr Pharmaceutical Announces Additions to Ophthalmic Scientific Advisory Board MENAFN.COM NEW YORK, NY, Jun 06, 2012 (MARKETWIRE via COMTEX) -- Ohr Pharmaceutical Inc. OHRP today announced the addition of two prominent ophthalmologists to its Scientific Advisory Board ("SAB") comprised of leading retinal ophthalmology experts to assist in ... See all stories on this topic »

Pfizer to cut 177 jobs in Cork Irish Times Pharmaceutical company Pfizer has announced it will cut 177 jobs at two plants in Co Cork. US pharmaceutical giant Pfizer has confirmed that it is to cut its workforce in Cork by 177 in response to a fall in demand for its leading anti-cholesterol drug ... See all stories on this topic » Irish Times

Eckert & Ziegler obtains manufacturing authorization for pharmaceutical ... MarketWatch (press release) BERLIN, Jun 06, 2012 (BUSINESS WIRE) -- Eckert & Ziegler Radiopharma GmbH, a subsidiary of Eckert & Ziegler AG, has been given the manufacturing authorization for its pharmaceutical (68)Ge/(68)Ga generators at the newly-built, GMP-compliant ... See all stories on this topic »

Pharmaceutical workers were braced for redundancy after management at Pfizer ... Irish Times Pharmaceutical workers were tonight braced for redundancy after management at Pfizer called a meeting with staff. Union bosses with Siptu want clarification from the firm amid reports it plans to cut 180 people from its production plants in Ringaskiddy ... See all stories on this topic » Irish Times

Takeda acquires URL Pharma for US$ 800 million pharmabiz.com Takeda Pharmaceuticals USA, Inc., (TPUSA), a wholly owned subsidiary, of Takeda Pharmaceutical Company Limited has completed the acquisition of URL Pharma, Inc. (URL Pharma) for an upfront payment of $800 million. The deal also includes an agreement ... See all stories on this topic »

Synergy Pharmaceuticals Announces Partial Exercise of Over-Allotment Option by ... MarketWatch (press release) NEW YORK, Jun 5, 2012 (GlobeNewswire via COMTEX) -- Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) , a developer of new drugs to treat gastrointestinal disorders and diseases, announced the partial exercise of the over-allotment option granted to the ... See all stories on this topic »

Drugmakers sound warning ahead of UK pricing talks Reuters UK Stephen Whitehead, chief executive of the Association of the British Pharmaceutical Industry, said Britain's pricing negotiations would decide the future of drug research in the country and companies would go abroad if incentives were cut. See all stories on this topic »

Mylan Canada Receives Health Canada Approval for Generic Version of Tracleer® MarketWatch (press release) PITTSBURGH and TORONTO, June 6, 2012 /PRNewswire via COMTEX/ -- Mylan Inc. (NASDAQ:MYL) today announced that its Canadian subsidiary, Mylan Pharmaceuticals ULC, has received approval from Health Canada for Mylan-Bosentan Tablets, 62.5 mg and 125 mg. See all stories on this topic »

Pharmaceutical Company Leaves Deerfield for Glenview Patch.com By Joanna Schneider Village of Glenview President Kerry Cummings, unknown, Dr. Steven Ryder, President of Astellas Pharma Global Development, Masao Yoshida, President & CEO Astellas US Pharma Inc. and Astellas US LLC, Representative Robert Dold, ... See all stories on this topic »

---

Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.

Delete this alert.
Create another alert.
Manage your alerts.